Atrial Fibrillation Treatment Market Amid Rising Cardiac Disorder Prevalence
Based on market forecasts, the atrial fibrillation treatment sector will expand from USD 24.26 billion in 2024 to USD 40.27 billion by 2034, experiencing a CAGR of 5.2%. Atrial fibrillation is a heart rhythm problem where the upper chambers quiver, raising the risk of blood clots. Causes include high blood pressure, heart disease, and sleep apnea. Hospitals lead the market due to infrastructure and teams, while specialty clinics grow rapidly with advanced treatments and skilled professionals.
Last Updated : 21 April 2026
Category: Medical Devices
Insight Code: 5120
Format: PDF / PPT / Excel